Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2017-07-10 Capital/Financing Update
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Appendix 3B 13 pages 722.2KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number and class of securities issued, issue price, purpose of the issue, shareholder approvals, and calculation of placement capacity under ASX Listing Rules 7.1 and 7.1A. It references specific ASX rules and includes sections on quotation of securities and agreements related to the new issue. The content is regulatory in nature, focused on capital raising and securities issuance rather than financial performance or management commentary. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document is lengthy (15,000 characters) and contains substantive details about the capital issuance, not merely an announcement of a report or a certification. Therefore, the appropriate classification is CAP.
2017-07-10 English
Notice of General Meeting/Proxy Form 30 pages 590.6KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING' and includes detailed information about resolutions to be voted on at a General Meeting, including ratification of share issues, approval of performance rights plans, and issuance of options. It contains proxy voting instructions, voting exclusion statements, and explanatory memoranda related to the meeting agenda. The document is clearly a notice and explanatory material for a shareholder meeting rather than a report of financial results or other filings. It is not an Annual Report, Earnings Release, or Management Report. It is also not a Proxy Solicitation or Voting Results announcement, but rather the notice and explanatory memorandum for the meeting itself. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or General Meeting. The document length and detail confirm it is the meeting notice and explanatory memorandum, not just a brief announcement or proxy form. Therefore, the correct classification is AGM Information (AGM-R).
2017-07-02 English
Change in substantial holding 2 pages 201.4KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder in BIOXYNE LIMITED. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is short and specific to shareholding changes, not a financial report or other type of filing.
2017-06-25 English
Appointment of Directors 2 pages 429.0KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 13 June 2017 regarding the appointment of new directors to the board of Bioxyne Limited. It details the backgrounds of the newly appointed directors and lists the current board members. There is no financial data, no mention of a report or financial results, and the content focuses solely on management changes. This fits the definition of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report or presentation. Therefore, the correct classification is MANG with high confidence.
2017-06-12 English
Becoming a substantial holder 3 pages 202.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001. It details the substantial shareholding of Nam Hoat Chua in Bioxyne Limited, including voting power, relevant interests, consideration paid, and associates. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory disclosure about shareholding thresholds being crossed.
2017-06-12 English
Directors Initial Interest Notice X 2 4 pages 507.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities interests of newly appointed directors, including shares and options held by the directors and their spouses. The content is focused on disclosure of personal shareholdings and interests of company directors. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests by company directors and executives. The document length is 4613 characters, which is sufficient to contain detailed information rather than just an announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2017-06-12 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.